The Price Increases That Should Cause Americans More Alarm

Wary of inflation, Americans have been watching the prices of everyday items such as eggs and gasoline. A less-noticed expense should cause greater alarm: rising premiums for health insurance. They have been trending upward for years and are now rising faster than ever. Consider that, from 2000 to 2020, egg prices fluctuated between just under…

Read More

Most Insurance Covers IUDs. Hers Cost More Than $14,000.

During her annual OB-GYN visit, Callie Anderson asked about getting off the birth control pill. “We decided the best option for me was an IUD,” she said, referring to an intrauterine device, a long-acting, reversible type of birth control. Anderson, 25, of Scranton, Pennsylvania, asked her doctor how much it might cost. At the time,…

Read More

CMS comes out with List of Drugs for 2027 Price Negotiation

From the CMS document “Medicare Drug Price Negotiation Program: Selected Drugs for Initial Price Applicability Year 2027“: On January 17, 2025, CMS announced the selection of the below list of 15 drugs covered under Medicare Part D for the second cycle of negotiations (initial price applicability year 2027), based on total gross covered prescription drug…

Read More

Carving a Path Toward Pragmatic Innovation in Clinical Trials

Prioritizing risk-based management, data science, smart automation, standards, and patient optionality are critical for the industry to keep up with market changes. The recent FDA guidance that encourages ‘pragmatic trials’ in specific scenarios is a move in the right direction. The post Carving a Path Toward Pragmatic Innovation in Clinical Trials appeared first on MedCity…

Read More

Bloom is Off the Rose at UnitedHealth Group

By JEFF GOLDSMITH A Forty Year Growth Saga is Coming to an End After market close Wednesday April 16, UnitedHealth Group reported its First Quarter 2025 earnings. UNH missed their expected 1Q earnings by 9 cents a share, but the firm also lowered its full year 2025 earnings estimate by 12%. On Thursday opening, investors…

Read More

What Do Early Stage Life Science Companies Need to Grow?

[Sponsored] Scheduled for May 8 at 1 pm ET, the conversation will include Morgan Cheatham, head of healthcare and life sciences at Breyer Capital, Gurdane Bhutani,  founder and managing partner of MBX Capital, and will be moderated by Mercury Head of Healthcare and Life Sciences Ben Kromnick. The post What Do Early Stage Life Science…

Read More

The Impact of HIV on Black People in the United States

Black people in the U.S. have been disproportionately affected by HIV since the epidemic’s beginning, and that disparity has deepened over time. Black people account for more new HIV diagnoses, people estimated to be living with HIV, and HIV-related deaths than any other racial/ethnic group in the U.S. This fact sheet provides an overview of…

Read More